CNE100004QP1
CNE100004QP1
MEDBOT-B
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 62/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±81.6% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.4x as much as the broader market.
Beta (Market Relation)
1.45x
Above averageVolatility (5Y p.a.)
81.6% p.a.
5-Year HorizonMax Drawdown (5Y)
-91.0%
5-Year HorizonSharpe Ratio
-0.21
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -30.9% |
| 3 Years | 80.9% | -70.9% | 0.04 | +5.7% |
| 5 Years | 81.6% | -91.0% | -0.21 | — |
| 10 Years | — | — | — | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 83.0 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (81.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -91.0% in the extended horizon.